Aimee Weisner Biography and Net Worth

Director of STAAR Surgical

Ms. Weisner most recently served as Corporate Vice President, General Counsel of Edwards Lifesciences Corporation from 2011 until her retirement in 2019. From 2009 to 2010, she was engaged in private practice and served as legal advisor to public pharmaceutical and medical device companies located in Southern California. Prior to this, from 2002 to 2009, Ms. Weisner served in a number of positions at Advanced Medical Optics, Inc. (acquired by Abbott Laboratories), including Executive Vice President, Administration and Secretary. From 1998 to 2002, Ms. Weisner served in a number of positions at Allergan, Inc., including Vice President, Assistant General Counsel and Assistant Secretary. Ms. Weisner began her legal career as an associate at the law firm of O’Melveny & Myers LLP. Ms. Weisner has served on the Board of Directors of Glaukos Corporation (NYSE: GKOS) since 2014, including as a member of its audit committee, and on the Board of Directors of Lensar, Inc. (Nasdaq: LNSR), including as a member of its compensation committee, since February 2021. Ms. Weisner previously served on the Board of Directors of Oyster Point Pharma, Inc. (NASDAQ: OYST) from 2019 to 2023. Ms. Weisner earned a B.A. from California State University, Fullerton, and a J.D. from Loyola Law School, Los Angeles.

What is Aimee S. Weisner's net worth?: The estimated net worth of Aimee S. Weisner is at least $486,120.66 as of August 8th, 2024. Ms. Weisner owns 30,119 shares of STAAR Surgical stock worth more than $486,121 as of April 17th. This net worth estimate does not reflect any other assets that Ms. Weisner may own. Learn More about Aimee S. Weisner's net worth.
How do I contact Aimee S. Weisner?: The corporate mailing address for Ms. Weisner and other STAAR Surgical executives is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. STAAR Surgical can also be reached via phone at (626) 303-7902 and via email at bmoore@staar.com. Learn More on Aimee S. Weisner's contact information.
Has Aimee S. Weisner been buying or selling shares of STAAR Surgical?: Aimee S. Weisner has not been actively trading shares of STAAR Surgical within the last three months. Most recently, on Thursday, March 14th, Aimee S. Weisner bought 1,750 shares of STAAR Surgical stock. The stock was acquired at an average cost of $38.11 per share, with a total value of $66,692.50. Following the completion of the transaction, the director now directly owns 10,864 shares of the company's stock, valued at $414,027.04. Learn More on Aimee S. Weisner's trading history.
Who are STAAR Surgical's active insiders?: STAAR Surgical's insider roster includes Hans-Martin Blickensdoerfer (VP), Arthur Butcher (Director), James Francese (VP), Samuel Gesten (Insider), Graydon Hansen (VP), Jon Hayashida (VP), Keith Holliday (CTO), Elizabeth Lin (Director), Caren Mason (CEO), Aimee Weisner (Director), and Patrick Williams (CFO). Learn More on STAAR Surgical's active insiders.
Are insiders buying or selling shares of STAAR Surgical?: During the last twelve months, STAAR Surgical insiders bought shares 19 times. They purchased a total of 1,849,773 shares worth more than $30,944,710.46. The most recent insider tranaction occured on April, 9th when Major Shareholder Broadwood Partners, L.P. bought 8,200 shares worth more than $123,656.00. Insiders at STAAR Surgical own 1.0% of the company. Learn More about insider trades at STAAR Surgical.
Information on this page was last updated on 4/9/2025.

Aimee S. Weisner Insider Trading History at STAAR Surgical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/14/2024	Buy	1,750	$38.11	$66,692.50	10,864
8/7/2023	Buy	2,000	$48.72	$97,440.00	5,417

Aimee S. Weisner Buying and Selling Activity at STAAR Surgical

STAAR Surgical Company Overview

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Today's Range

Now: $16.14

$15.97

$16.72

50 Day Range

MA: $17.29

$15.09

$22.61

2 Week Range

Now: $16.14

$13.50

$49.86

Volume

636,463 shs

Average Volume

790,486 shs

Market Capitalization

$796.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.75